| # | Drug | Count |
|---|---|---|
| 0 | GANCICLOVIR SODIUM | 176 |
| 1 | FOSCARNET SODIUM | 172 |
| 2 | GANCICLOVIR | 171 |
| 3 | CYCLOPHOSPHAMIDE | 159 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 159 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 159 |
| 6 | FLUDARABINE PHOSPHATE | 147 |
| 7 | VALGANCICLOVIR | 147 |
| 8 | VALGANCICLOVIR HYDROCHLORIDE | 147 |
| 9 | RITUXIMAB | 142 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 70 | 0.1440 |
| 1 | FOSCARNET SODIUM | 172 | 0.0427 |
| 2 | LETERMOVIR | 75 | 0.0230 |
| 3 | GANCICLOVIR SODIUM | 176 | 0.0164 |
| 4 | CIDOFOVIR ANHYDROUS | 12 | 0.0083 |
| 5 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 67 | 0.0082 |
| 6 | VALGANCICLOVIR | 147 | 0.0077 |
| 7 | ACYCLOVIR SODIUM | 5 | 0.0040 |
| 8 | FLUDARABINE PHOSPHATE | 147 | 0.0037 |
| 9 | IBRITUMOMAB TIUXETAN | 5 | 0.0033 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 75 | 0.0230 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 203 | 0.0091 |
| 2 | Human Immunoglobulin G [EPC] | 77 | 0.0037 |
| 3 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 8 | 0.0032 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 9 | 0.0022 |
| 5 | Nucleoside Analog Antiviral [EPC] | 171 | 0.0020 |
| 6 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 7 | CD19-directed Chimeric Antigen Receptor [EPC] | 12 | 0.0012 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 130 | 0.0010 |
| 9 | Alkylating Drug [EPC] | 195 | 0.0008 |